Bioequivalence studies for GCC submission [Design Issues]

posted by professionalr – India, 2025-01-31 00:00 (43 d 11:50 ago) – Posting: # 24353
Views: 562

Hi friends,
Would it be acceptable to conduct bioequivalence studies for GCC submission at CRO if the facility has already been inspected by the US FDA? We don’t have separate GCC facility approval.

Thanks,
RP.

Complete thread:

UA Flag
Activity
 Admin contact
23,409 posts in 4,921 threads, 1,665 registered users;
18 visitors (1 registered, 17 guests [including 7 identified bots]).
Forum time: 11:50 CET (Europe/Vienna)

Tortured data will confess to anything.    Fredric Menger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5